학술논문

A phase I/II study of the mTOR inhibitor everolimus in combination with hyperCVAD chemotherapy in patients with relapsed/refractory acute lymphoblastic leukemia
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 15 June 2015, 21(12):2704-2714)
Subject
Language
English
ISSN
15573265
10780432